Koo-Han相关文献与解析，生知库 | 链接生命科学的每一步

Chromatin regulators TOP2A and PPARGC1A stratify prostate cancer risk and reveal TOP2A-driven progression via PI3K/AKT pathway

染色质调节因子TOP2A和PPARGC1A可对前列腺癌风险进行分层，并揭示TOP2A通过PI3K/AKT通路驱动的肿瘤进展。

doi:10.21147/j.issn.1000-9604.2026.01.06

Wang, Zhipeng; Wang, Jie; Chen, Shuang; Wu, Ruicheng; Tuo, Zhouting; Ye, Luxia; Yoo, Koo Han; Li, Dengxiong; Jin, Xiaodong; Xiong, Wei; Feng, Dechao

The prognostic value of the lung immune prognostic index in patients with urological cancers: a systematic review and meta-analysis

肺免疫预后指数在泌尿系统肿瘤患者中的预后价值：系统评价和荟萃分析

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2026.1806105

Lyu, Zhaojie; Xiao, Yuhan; Wang, Jie; Wu, Ruicheng; Yoo, Koo Han; Wei, Wuran; Zhang, Qi; Xie, Yandong; Feng, Dechao

Harnessing Ribonucleoprotein Granule Biology for Cancer Therapy: The Central Role of Protein Modifications

利用核糖核蛋白颗粒生物学进行癌症治疗：蛋白质修饰的核心作用

期刊:

影响因子:

doi:10.34133/research.1133

Li, Dengxiong; Yu, Qingxin; Wu, Ruicheng; Yoo, Koo Han; Wusiman, Dilinaer; Wang, Jie; Zhang, Qi; Feng, Dechao

Intratumoral Androgens and Genetic Variants Driving Therapy Resistance in Prostate Cancer

肿瘤内雄激素和基因变异驱动前列腺癌的治疗耐药性

期刊:

影响因子:

doi:10.34133/research.1128

Ye, Junjiang; Xie, Yandong; Wang, Jie; Wu, Ruicheng; Li, Dengxiong; Yoo, Koo Han; Wusiman, Dilinaer; Cho, William C; Lyu, Zhaojie; Feng, Dechao

Peripheral Nerve-Cancer Interactions in the Tumor Microenvironment: A Three-Dimensional Framework Integrating Mechanisms, Modulators, and Therapeutic Strategies

肿瘤微环境中周围神经与癌症的相互作用：整合机制、调节因子和治疗策略的三维框架

期刊:

影响因子:

doi:10.34133/research.1221

Shao, Fanglin; Wang, Jie; Li, Aiqing; Wu, Ruicheng; Chen, Jiamin; Tuo, Zhouting; Wusiman, Dilinaer; Yoo, Koo Han; Wei, Wuran; Wang, Zhipeng; Li, Dengxiong; Zhang, Qi; Guo, Yuanning; Feng, Dechao

Global burden and cross-country inequalities in urinary tumors from 1990 to 2021 and predicted incidence changes to 2046

1990年至2021年全球泌尿系统肿瘤负担及各国间不平等现象，以及预测至2046年的发病率变化

期刊:Military Medical Research

影响因子:22.9

doi:10.1186/s40779-025-00599-y

Feng, De-Chao; Li, Deng-Xiong; Wu, Rui-Cheng; Wang, Jie; Xiao, Yu-Han; Yoo, Koo Han; Ye, Xing; Wei, Wu-Ran; Kong, De-Pei; Tuo, Zhou-Ting

Tracing the Evolution of Sex Hormones and Receptor-Mediated Immune Microenvironmental Differences in Prostate and Bladder Cancers: From Embryonic Development to Disease

追踪前列腺癌和膀胱癌中性激素和受体介导的免疫微环境差异的演变：从胚胎发育到疾病

期刊:Advanced Science

影响因子:14.1

doi:10.1002/advs.202407715

Li, Dengxiong; Wang, Zhipeng; Yu, Qingxin; Wang, Jie; Wu, Ruicheng; Tuo, Zhouting; Yoo, Koo Han; Wusiman, Dilinaer; Ye, Luxia; Guo, Yiqing; Yang, Yubo; Shao, Fanglin; Shu, Ziyu; Okoli, Uzoamaka; Cho, William C; Wei, Wuran; Feng, Dechao

Advances in nanomaterials for enhancing cGAS-STING pathway mediated anti-tumor treatment

纳米材料在增强cGAS-STING通路介导的抗肿瘤治疗中的应用进展

期刊:Materials Today Bio

影响因子:10.2

doi:10.1016/j.mtbio.2025.102190

Wu, Ruicheng; Wang, Jie; Li, Dengxiong; Li, Ao; Yoo, Koo Han; Liu, Zhihong; Wei, Wuran; Wang, Zhipeng; Feng, Dechao

Mitochondrial function meets oncology: the multifaceted role of TFAM across cancer types

线粒体功能与肿瘤学：TFAM在各种癌症类型中的多重作用

Targeting urological cancers with CAR-T cell therapy: current landscape and future directions

利用 CAR-T 细胞疗法靶向治疗泌尿系统癌症：现状与未来方向

Chromatin regulators TOP2A and PPARGC1A stratify prostate cancer risk and reveal TOP2A-driven progression via PI3K/AKT pathway

染色质调节因子TOP2A和PPARGC1A可对前列腺癌风险进行分层，并揭示TOP2A通过PI3K/AKT通路驱动的肿瘤进展。

The prognostic value of the lung immune prognostic index in patients with urological cancers: a systematic review and meta-analysis

肺免疫预后指数在泌尿系统肿瘤患者中的预后价值：系统评价和荟萃分析

Harnessing Ribonucleoprotein Granule Biology for Cancer Therapy: The Central Role of Protein Modifications

利用核糖核蛋白颗粒生物学进行癌症治疗：蛋白质修饰的核心作用

Intratumoral Androgens and Genetic Variants Driving Therapy Resistance in Prostate Cancer

肿瘤内雄激素和基因变异驱动前列腺癌的治疗耐药性

Peripheral Nerve-Cancer Interactions in the Tumor Microenvironment: A Three-Dimensional Framework Integrating Mechanisms, Modulators, and Therapeutic Strategies

肿瘤微环境中周围神经与癌症的相互作用：整合机制、调节因子和治疗策略的三维框架

Global burden and cross-country inequalities in urinary tumors from 1990 to 2021 and predicted incidence changes to 2046

1990年至2021年全球泌尿系统肿瘤负担及各国间不平等现象，以及预测至2046年的发病率变化

Tracing the Evolution of Sex Hormones and Receptor-Mediated Immune Microenvironmental Differences in Prostate and Bladder Cancers: From Embryonic Development to Disease

追踪前列腺癌和膀胱癌中性激素和受体介导的免疫微环境差异的演变：从胚胎发育到疾病

Advances in nanomaterials for enhancing cGAS-STING pathway mediated anti-tumor treatment

纳米材料在增强cGAS-STING通路介导的抗肿瘤治疗中的应用进展